Evidence for a defect in NADH
- 1 August 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 40 (8) , 1231
- https://doi.org/10.1212/wnl.40.8.1231
Abstract
We evaluated electron transport chain activity in platelet mitochondria taken from HD patients. All 5 patients studied had striking depressions of NADH: ubiquinone oxidoreductase activity (complex I) (5.36 ± 2.91 nmol/min/mg; control mean, 19.12 ± 5.64 nmol/min/mg). Other electron transport chain activities were not significantly different from control values. HD may be caused by a mutation in 1 of the nuclear coded subunits of NADH: ubiquinone oxidoreductase.This publication has 13 references indexed in Scilit:
- URF6, Last Unidentified Reading Frame of Human mtDNA, Codes for an NADH Dehydrogenase SubunitScience, 1986
- The diagnosis of Huntington's diseaseNeurology, 1986
- Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.Journal of Biological Chemistry, 1986
- Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenaseNature, 1985
- A polymorphic DNA marker genetically linked to Huntington's diseaseNature, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Effects of Kainic Acid on High‐Energy Metabolites in the Mouse StriatumJournal of Neurochemistry, 1982
- Maternal inheritance of human mitochondrial DNA.Proceedings of the National Academy of Sciences, 1980
- An analysis of the polypeptide composition of bovine heart mitochondrial NADH-ubiquinone oxidoreductase by two-dimensional polyacrylamide-gel electrophoresisBiochemical Journal, 1979
- Huntington diseaseNeurology, 1979